zoledronic acid has been researched along with Glioblastoma in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 5 (83.33) | 24.3611 |
| 2020's | 1 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Abate, M; Biondi, M; Campani, V; Caraglia, M; De Rosa, G; Leonetti, C; Nele, V; Porru, M; Scotti, L; Zappavigna, S | 1 |
| Hironaka, Y; Marutani, A; Matsuda, R; Motoyama, Y; Nakagawa, I; Nakamura, M; Nakase, H; Nakazawa, T; Nishimura, F; Ouji, N; Ouji, Y; Park, YS; Sugimoto, T; Takeshima, Y; Tamura, K; Tsujimura, T; Yamada, S; Yoshikawa, M | 1 |
| Artuso, S; Balestrieri, ML; Caraglia, M; De Rosa, G; Leonetti, C; Luce, A; Lusa, S; Porru, M; Salzano, G; Stoppacciaro, A; Zappavigna, S | 1 |
| Artuso, S; Balestrieri, ML; Caraglia, M; D'Onofrio, N; De Rosa, G; Grimaldi, A; Ingrosso, D; Leonetti, C; Luce, A; Lusa, S; Porru, M; Salzano, G; Zappavigna, S | 1 |
| Chien, S; Guo, F; Jiang, P; Kesari, S; Mukthavaram, R; Nomura, N; Pingle, SC; Teng, D; Zhang, P | 1 |
| Bowersock, J; Dasgupta, A; Gillespie, GY; Johnson, A; Lamb, LS; Spencer, HT; Su, Y | 1 |
6 other study(ies) available for zoledronic acid and Glioblastoma
| Article | Year |
|---|---|
Hybrid Self-Assembling Nanoparticles Encapsulating Zoledronic Acid: A Strategy for Fostering Their Clinical Use.
Topics: Animals; Diphosphonates; Freeze Drying; Glioblastoma; Mice; Nanoparticles; Sucrose; Trehalose; Zoledronic Acid | 2022 |
Cytotoxic human peripheral blood-derived γδT cells kill glioblastoma cell lines: implications for cell-based immunotherapy for patients with glioblastoma.
Topics: Analysis of Variance; Antigens, CD; Bone Density Conservation Agents; Cell Line, Tumor; Diphosphonates; Flow Cytometry; Fluoresceins; Glioblastoma; Humans; Imidazoles; Leukocytes, Mononuclear; Lymphocyte Activation; Receptors, Antigen, T-Cell, gamma-delta; T-Lymphocyte Subsets; Time Factors; Zoledronic Acid | 2014 |
Medical treatment of orthotopic glioblastoma with transferrin-conjugated nanoparticles encapsulating zoledronic acid.
Topics: Animals; Apoptosis; Blood-Brain Barrier; Brain Neoplasms; Cell Growth Processes; Cell Line, Tumor; Dacarbazine; Diphosphonates; Drug Delivery Systems; Drug Resistance, Neoplasm; Glioblastoma; Humans; Imidazoles; Male; Mice; Mice, Inbred Strains; Nanoparticles; Nitrosourea Compounds; Organophosphorus Compounds; Temozolomide; Transferrin; Tumor Burden; Xenograft Model Antitumor Assays; Zoledronic Acid | 2014 |
Transferrin-Targeted Nanoparticles Containing Zoledronic Acid as a Potential Tool to Inhibit Glioblastoma Growth.
Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Cell Survival; Diffusion; Diphosphonates; Glioblastoma; Imidazoles; Male; Mice; Mice, Nude; Molecular Targeted Therapy; Nanocapsules; Receptors, Transferrin; Transferrin; Treatment Outcome; Zoledronic Acid | 2016 |
Anti-cancer effects of nitrogen-containing bisphosphonates on human cancer cells.
Topics: Animals; Antineoplastic Agents; Autophagy; Bone Density Conservation Agents; Brain Neoplasms; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Diphosphonates; Drug Screening Assays, Antitumor; Glioblastoma; Humans; Imidazoles; MCF-7 Cells; Mice; Neoplasm Transplantation; Nitrogen; Zoledronic Acid | 2016 |
Engineered drug resistant γδ T cells kill glioblastoma cell lines during a chemotherapy challenge: a strategy for combining chemo- and immunotherapy.
Topics: Antineoplastic Agents, Alkylating; Brain Neoplasms; Cell Line, Tumor; Cell Survival; Cells, Cultured; Cytotoxicity, Immunologic; Dacarbazine; Diphosphonates; Drug Resistance, Neoplasm; Flow Cytometry; Genetic Engineering; Genetic Vectors; Glioblastoma; GPI-Linked Proteins; Humans; Imidazoles; Intercellular Signaling Peptides and Proteins; Interleukin-2; Lentivirus; O(6)-Methylguanine-DNA Methyltransferase; Receptors, Antigen, T-Cell, gamma-delta; T-Lymphocytes; Temozolomide; Zoledronic Acid | 2013 |